Expertise in
2
conditions

John Conibear

St Bartholomew's Hospital, 
London, ENG, GB 
Expertise in
2
conditions
St Bartholomew's Hospital, 
London, ENG, GB 

Overview

John Conibear practices practicing medicine in London, United Kingdom.

Mr. Conibear is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Cardiac Tamponade, and Breast Cancer.

He is actively involved in clinical research, co-authoring 33 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

St Bartholomew's Hospital, London, ENG, United Kingdom
Other Locations
Oxford, ENG, United Kingdom
Mount Vernon Cancer Centre
Northwood, ENG, United Kingdom
Mount Vernon Centre For Cancer Treatment, Middlesex, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

TRAcking Non-small Cell Lung Cancer Evolution Through Therapy (Rx)
TRAcking Non-small Cell Lung Cancer Evolution Through Therapy (Rx)
Enrollment Status: Active_not_recruiting
Publish Date: May 04, 2026
National Lung Matrix Trial: Multi-drug, Genetic Marker-directed, Non-comparative, Multi-centre, Multi-arm Phase II Trial in Non-small Cell Lung Cancer
National Lung Matrix Trial: Multi-drug, Genetic Marker-directed, Non-comparative, Multi-centre, Multi-arm Phase II Trial in Non-small Cell Lung Cancer
Enrollment Status: Completed
Publish Date: April 28, 2026
Intervention Type: Drug
Study Drugs: AZD4547, Vistusertib, Palbociclib, Crizotinib, Selumetinib, Docetaxel, AZD5363, Osimertinib, Durvalumab, Sitravatinib, AZD6738
Study Phase: Phase 2
View 1 Less Clinical Trial

33 Total Publications

Curative-Intent Radiotherapy in the Era of Earlier Lung Cancer Diagnosis: Insights from the National Lung Cancer Audit.
Curative-Intent Radiotherapy in the Era of Earlier Lung Cancer Diagnosis: Insights from the National Lung Cancer Audit.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: March 31, 2026

Frequently Asked Questions about John Conibear

Is John Conibear a top-rated expert for Lung Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. John Conibear is classified as an Advanced expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does John Conibear participate in research or clinical trials?

Yes. John Conibear has published 33 articles and abstracts on conditions like Lung Cancer. You can view a list of John Conibear's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Conibear's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile